AIIMS Bhubaneswar will start kidney transplantation surgery from July. The institution has already received permission from the Directorate of Medical Education and Training (DMET) of the state government to start the procedure. Sachidananda Mohanty, medical superintendent of AIIMS Bhubaneswar, said they have a complete setup in the hospital to start kidney transplant. “DMET has given approval for this and we have trained manpower for the procedure. We are expecting our first case by July 15,” he added. He said doctors from two departments — nephrology and urology — will play vital roles in the surgeries.

Monkeypox virus is not as contagious or severe as COVID-19, however, its spread is a matter of concern, Dr NK Arora, Chairman of the COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI), said on Wednesday. He said the Centre has set up an expert committee for this.

Some of India's hospitals are set to upgrade the quality of their services leveraging space technology in emergency care and critical care departments thanks to ISRO. Many healthcare associations approached ISRO in 2016 to learn the best practices in its quality domain and implement them in their emergency care and critical care departments "for reducing mortality rates." They included Association of Healthcare Providers (India) (AHPI), Indian Society of Critical Care Medicine (ISCCM), Society for Emergency Medicine India (SEMI), and the Consortium of Accredited Healthcare Organisations (CAHO), according to ISRO (Indian Space Research Organisation).

New U.S. research on long COVID-19 provides fresh evidence that it can happen even after breakthrough infections in vaccinated people, and that older adults face higher risks for the long-term effects. In a study of veterans published Wednesday, about one-third who had breakthrough infections showed signs of long COVID. A separate report from the Centers for Disease Control and Prevention found that up to a year after an initial coronavirus infection, 1 in 4 adults aged 65 and older had at least one potential long COVID health problem, compared with 1 in 5 younger adults.

Cadila Pharma has launched a novel drug for the treatment of high LDL cholesterol for the first time in India. To be sold under the brand name Belmore, Bempedoic acid is a one-of-its-kind drug for the treatment of high Low-Density Lipoprotein (LDL) cholesterol, also known as bad cholesterol, a company statement said. As per published data, more than 30 percent of adults in urban areas and 20 percent in rural areas in India are suffering from the disease. Statins are the group of drugs used to control LDL cholesterol but in more than 80 percent of the patients, these drugs either do not give optimum control or are not tolerated, the statement said.